BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29085663)

  • 1. Isoform specificity of progesterone receptor antibodies.
    Fabris V; Abascal MF; Giulianelli S; May M; Sequeira GR; Jacobsen B; Lombès M; Han J; Tran L; Molinolo A; Lanari C
    J Pathol Clin Res; 2017 Oct; 3(4):227-233. PubMed ID: 29085663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of progesterone receptor forms A and B by immunohistochemical analysis.
    Mote PA; Johnston JF; Manninen T; Tuohimaa P; Clarke CL
    J Clin Pathol; 2001 Aug; 54(8):624-30. PubMed ID: 11477119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    Rojas PA; May M; Sequeira GR; Elia A; Alvarez M; Martínez P; Gonzalez P; Hewitt S; He X; Perou CM; Molinolo A; Gibbons L; Abba MC; Gass H; Lanari C
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 28376177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1.
    Abascal MF; Elia A; Alvarez M; Pataccini G; Sequeira G; Riggio M; Figueroa V; Lamb CA; Rojas PA; Spengler E; Martínez-Vazquez P; Burruchaga J; Liguori M; Sahores A; Wargon V; Molinolo A; Hewitt S; Lombes M; Sartorius C; Vanzulli SI; Giulianelli S; Lanari C
    Int J Cancer; 2022 May; 150(9):1481-1496. PubMed ID: 34935137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
    Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
    Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
    Leslie KK; Stein MP; Kumar NS; Dai D; Stephens J; Wandinger-Ness A; Glueck DH
    Gynecol Oncol; 2005 Jan; 96(1):32-41. PubMed ID: 15589577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor isoforms PRA and PRB differentially contribute to breast cancer cell migration through interaction with focal adhesion kinase complexes.
    Bellance C; Khan JA; Meduri G; Guiochon-Mantel A; Lombès M; Loosfelt H
    Mol Biol Cell; 2013 May; 24(9):1363-74. PubMed ID: 23485561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.
    Mote PA; Bartow S; Tran N; Clarke CL
    Breast Cancer Res Treat; 2002 Mar; 72(2):163-72. PubMed ID: 12038707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.
    Pateetin P; Pisitkun T; McGowan E; Boonyaratanakornkit V
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105560. PubMed ID: 31809870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of hepatic progesterone and estrogen receptors in the female turtle, Chrysemys picta: relationship to vitellogenesis.
    Custodia-Lora N; Novillo A; Callard IP
    Gen Comp Endocrinol; 2004 Apr; 136(2):232-40. PubMed ID: 15028527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland.
    Aupperlee MD; Haslam SZ
    Endocrinology; 2007 May; 148(5):2290-300. PubMed ID: 17317767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor isoform B expression in pulmonary neuroendocrine cells decreases cell proliferation.
    Asavasupreechar T; Saito R; Edwards DP; Sasano H; Boonyaratanakornkit V
    J Steroid Biochem Mol Biol; 2019 Jun; 190():212-223. PubMed ID: 30926428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of breast cancer-associated genes by progesterone receptor isoforms PRA and PRB in a new bi-inducible breast cancer cell line.
    Khan JA; Bellance C; Guiochon-Mantel A; Lombès M; Loosfelt H
    PLoS One; 2012; 7(9):e45993. PubMed ID: 23029355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subnuclear distribution of progesterone receptors A and B in normal and malignant endometrium.
    Arnett-Mansfield RL; DeFazio A; Mote PA; Clarke CL
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1429-42. PubMed ID: 15001645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.
    Arnett-Mansfield RL; deFazio A; Wain GV; Jaworski RC; Byth K; Mote PA; Clarke CL
    Cancer Res; 2001 Jun; 61(11):4576-82. PubMed ID: 11389093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of overexpression of progesterone receptor A on endogenous progestin-sensitive endpoints in breast cancer cells.
    McGowan EM; Clarke CL
    Mol Endocrinol; 1999 Oct; 13(10):1657-71. PubMed ID: 10517668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulipristal Acetate Inhibits Progesterone Receptor Isoform A-Mediated Human Breast Cancer Proliferation and BCl2-L1 Expression.
    Esber N; Le Billan F; Resche-Rigon M; Loosfelt H; Lombès M; Chabbert-Buffet N
    PLoS One; 2015; 10(10):e0140795. PubMed ID: 26474308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development.
    Aupperlee MD; Smith KT; Kariagina A; Haslam SZ
    Endocrinology; 2005 Aug; 146(8):3577-88. PubMed ID: 15878961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of progesterone receptors A and B in the mouse ovary during the estrous cycle.
    Gava N; Clarke CL; Byth K; Arnett-Mansfield RL; deFazio A
    Endocrinology; 2004 Jul; 145(7):3487-94. PubMed ID: 15044369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.
    Sequeira G; Vanzulli SI; Rojas P; Lamb C; Colombo L; May M; Molinolo A; Lanari C
    Oncotarget; 2014 May; 5(10):3246-60. PubMed ID: 24912774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.